title: Prostate cancer screening rates remain stable despite recommendations against testing men with limited life expectancy.
authors.forename: Mary Kay
authors.initials: MK
authors.lastname: Barton
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008017:Life Expectancy; D008297:Male; D008403:Mass Screening / Q000706:statistics & numerical data*; D018579:Patient Selection; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D014481:United States
chemical_list: D017430:Prostate-Specific Antigen